Pacific Biosciences Of California | PACB - Des Atouts





Des Atouts Changement Date
Agilent USD 12.81B 86M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Danaher USD 83.46B 3.57B 2025-12
General Electric Aerospace USD 130.17B 1.93B 2025-12
Illumina USD 6.64B 467M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
Pacific Biosciences Of California USD 784.08M 19.08M 2025-12
Quidel USD 5.77B 94.2M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Standard Biotools USD 567.75M 28.12M 2025-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Waters USD 5.08B 221.41M 2025-12